Cash Runway Isn't a Number. It's a Strategy.

What's your cash runway?

It's one of the first questions founders are asked by investors, board members, and advisors. And it's usually answered the same way:

"We have approximately 14 months of runway."

Simple enough. Or is it?

The truth is, cash runway is not a number. It's a strategy.

Two development-stage life science companies can each have $5 million in cash and dramatically different runway projections. Why? Because cash runway is not determined solely by your bank balance or monthly burn rate. It's determined by the operational and strategic decisions your company makes every day.

Hiring plans. Clinical timelines. Regulatory milestones. Manufacturing activities. Capital allocation decisions. Financing assumptions. Vendor contracts. Strategic priorities.

Every one of these decisions impacts how long your capital lasts and whether it is aligned with your development plan.

Yet many early-stage companies continue to manage cash runway as a static calculation:

Beginning Cash ÷ Monthly Burn = Runway

While convenient, this approach fails to reflect the reality of how development-stage companies operate.

Cash Runway Is the Output of Your Operating Strategy

Your cash runway is not an accounting exercise. It is the financial manifestation of your operating plan.

Consider just a few common scenarios:

• Your IDE approval is delayed by three months.

• Clinical enrollment takes twice as long as anticipated.

• Manufacturing costs increase by 20%.

• You decide to hire a Chief Medical Officer earlier than planned.

• Your lead investor asks you to accelerate commercialization activities.

• You receive grant funding sooner than expected.

Each of these decisions changes your cash runway.

The question isn't, "How many months of cash do we have?"

The better questions are:

• What are we trying to accomplish?

• What will it cost?

• When will those costs occur?

• How much capital will we need and when?

• What happens if our assumptions change?

Cash runway is simply the output of those answers.

Static Forecasts Fail the Moment Reality Changes

Development-stage life science companies are dynamic by nature. Timelines shift. Milestones move. Scientific discoveries alter priorities. Financing strategies evolve.

The problem is that many financial forecasts don't evolve with them.

Instead, companies rely on static spreadsheets that require manual updates every time assumptions change. Over time, the forecast becomes disconnected from operational reality.

The result?

• Cash runway becomes inaccurate.

• Financing requirements become unclear.

• Board discussions become reactive.

• Investor confidence begins to erode.

When capital is scarce—as it often is in today's funding environment—understanding the operational drivers of cash runway isn't a luxury. It's a requirement.

Cash Runway Should Drive Strategic Conversations

Successful development-stage companies don't simply report cash runway each month. They actively manage it.

They understand how operational decisions impact capital requirements before those decisions are made.

They ask questions like:

• Can we afford to hire now or should we wait until our next financing?

• What happens if enrollment is delayed by one quarter?

• Can we extend runway by delaying a milestone without impacting value creation?

• How much capital should we raise based on our development plan—not our burn rate?

• What milestones should we achieve before returning to the market for financing?

Cash runway is not something that happens to a company. It is something management strategically plans for and continuously manages.

Capital Strategy and Operating Strategy Must Be Connected

The single largest mistake we see in development-stage life science companies is treating capital strategy and operating strategy as separate conversations.

They aren't.

Your operating plan determines your capital needs. Your capital plan determines what you can accomplish operationally. Neither exists independently of the other.

Ultimately, cash runway is not a number on a board slide or a line item in a forecast.

It is the financial story of your company's ability to execute its mission.

At Fractional Finance Solutions, we believe cash runway should be dynamic, milestone-driven, and directly connected to the operational realities of development-stage life science companies.

Because the most valuable number in your forecast isn't your cash balance—it's the confidence behind the assumptions that drive it.